PURETECH HEALTH ORD 1P

- GBX (-)

- 15 min delayed data - London Stock Exchange

Open:	-
Change:	-
Volume:	-

Low:	-
High:	-
High / Low range:	-

Type:	Stocks
Ticker:	PRTC
ISIN:	GB00BY2Z0H74

PURETECH HEALTH ORD 1P overview

> News EQS Group published a news.

Form 8.3 - The Vanguard Group, Inc.: PureTech Health plc • • EQS Group • Stocks • More PURETECH HEALTH ORD 1P news...

The Vanguard Group, Inc. ( ) Form 8.3 - The Vanguard Group, Inc.: PureTech Health plc 10-Oct-2022 / 14:18 GMT/BST Dissemination of a Regulatory Announcement, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement. FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: The Vanguard...

Thank you Chart

> Analyses

Londinia AI has published a new analysis for Vincent Launay.

0
72772
15109
0

PURETECH HEALTH ORD 1P - Daily

Timeframe : Daily - Simple chart
Status : TARGET REACHED

The basic trend is bullish on PURETECH HEALTH ORD 1P and in the short term, the price is attempting to correct. For the time being, this is only a simple technical correction and the basic trend is…

Thank you Reply Chart

> News Business Wire published a news.

PureTech Health to Present at Two Upcoming Investor Conferences • • Business Wire • Stocks • More PURETECH HEALTH ORD 1P news...

PureTech Health plc (LSE: PRTC) (“PureTech Health”), an advanced biopharmaceutical company developing novel medicines for dysfunctions of the Brain-Immune-Gut (BIG) Axis, today announced two presentations at upcoming investor conferences. Daphne Zohar, co-founder and chief executive officer, will present at the SVB Leerink Global Healthcare Conference in New York on Friday, March 1, at 11:30 AM EST. Additionally, Joep Muijrers, PhD, chief financial officer, will present at the Cowen and...

Thank you Chart

Load more content